基因行业蓝皮书（2024-2025）

Investment Rating - The report does not explicitly state an investment rating for the gene industry Core Insights - The gene industry is positioned as a strategic emerging industry with significant growth potential, driven by advancements in gene technology and its applications in healthcare, agriculture, and industrial sectors [28][34][40] - The market for gene technology is expected to expand from billions to trillions, with gene testing, therapy, and synthesis being the core areas of focus [23][36] - The report emphasizes the importance of innovation and collaboration within the industry to enhance competitiveness and address market challenges [24][42] Summary by Sections Section 1: Industry Connotation - The essence of the gene industry lies in the digitization of life, utilizing high-resolution and real-time technologies to showcase health characteristics and apply them across various sectors [28][30] - Gene technology is a cornerstone of biological economy, integrating molecular biology and bioinformatics, and is recognized as a strategic frontier technology [32][34] Section 2: Development Environment and Current Status - The global gene industry is experiencing uneven development, with gene testing being the most mature segment, while gene therapy and synthesis are in earlier stages [41][42] - Regulatory policies vary significantly across countries, with developed regions generally providing more supportive environments for gene technology [44] Section 3: Application Scenarios - Gene technology is applied in reproductive health, cancer treatment, rare diseases, and infectious disease diagnostics, with significant advancements in non-invasive prenatal testing (NIPT) and pre-implantation genetic testing [36][37] - The agricultural sector is leveraging gene editing and synthetic biology for improved crop breeding and soil enhancement [37] Section 4: Common Technologies and Production Platforms - Key technologies include PCR, high-throughput sequencing, gene editing, and synthesis, which are essential for advancing the gene industry [31] Section 5: Industry Chain and Supply Chain Map - The gene industry supply chain is dominated by a few leading companies, with increasing competition and collaboration among various stakeholders [41][42] Section 6: Investment and Financing Analysis - The report highlights the need for increased investment in gene technology to support long-term research and development, particularly in the face of economic challenges [23][24] Section 7: Regional Development and Industrial Parks - The establishment of gene-related industrial parks and incubators is crucial for fostering innovation and collaboration within the industry [10] Section 8: Industry Development Trends and Recommendations - The report calls for a focus on innovation-driven development, emphasizing the need for differentiated strategies and the establishment of industry standards to enhance global competitiveness [24][42]